OVIDREL

Google image searchProduct monograph

Active ingredient

choriogonadotropin alfa, 250 MCG/0.5 ML

DIN: 02371588

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 1 PRE-FILLED PEN OF 250 µG SOLUTION FOR INJECTION

Schedule: Prescription / Schedule D

Company: EMD SERONO, A DIVISION OF EMD INC., CANADA

Date: 28-MAY-2013

ATC:

Reference brand drug: Ovidrel

Search on Google